OECD Virtual Workshop - 19 & 20 May 2021 hosted by the Swiss Delegation - Fondation Ipsen
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Working Party on Bio-, Nano- and Converging Technologies (BNCT)
19 & 20 May 2021
OECD Virtual Workshop
hosted by the Swiss Delegation
oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Agenda outline
Day 1 Day 2
Wednesday, 19 May 2021 (13h00-16h30 CEST) Thursday, 20 May 2021 (13h00-16h45 CEST)
13h00-13h15 13h00-13h05
Opening by the Chair and welcome messages Welcome and summary of day 1
13h15-14h00 - keynote 13h05-13h35 - keynote
Economic stakes and potential health impacts of neurotechnologies Convergence of neurotechnology with other emerging technologies
14h00-15h00 - panel 13h35-14h55 - panel
Building institutional capacity to implement the Recommendation – Promoting stewardship and trust across the public and private sector
the Swiss experience
14h55-15h05 - break
15h00-15h10 - break
15h05-15h25 - expert talk
15h10-16h30 - panel Monitoring implementation activities - towards the development of
Enabling societal deliberation on neurotechnology indicators
15h25-16h35 - roundtable
Next steps in the implementation of the Recommendation
16h35-16h45
Closing remarks and next steps
1 oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Workshop overview
Neurotechnology has great potential for improving societal health and
well-being. Yet, just as with many other emerging technologies, it faces
ethical, legal, and social challenges (ELSI). In the absence of international
instruments in this field, the OECD Council adopted a Recommendation
on Responsible Innovation in Neurotechnology in December 2019.
This two-day virtual workshop on 19-20 May 2021 is hosted by the Swiss
Delegation in Zurich and focuses on issues of societal deliberation,
stewardship and trust that are vital in the notion of Neurotechnology in
and for society. It focuses on Principle 5 (Enable societal deliberation on
neurotechnology) and Principle 8 (Promote cultures of stewardship and
trust in neurotechnology across the public and private sector) in the
Recommendation.
Workshop objectives
► Share initiatives, good practices and experiences related to Principles 5
and 8 of the Recommendation;
► Engage stakeholders in a critical discussion on what worked and what
needs to be improved to implement the Recommendation;
► Explore how the Recommendation fits with and could be implemented
in national and transnational activities in the future;
► Generate insights which inform guidance resources for adherents and
fuel future discussions.
2 oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Opening by the Chair, welcome messages and commentaries
19 May 2021, 13h00-13h15 CEST
FRANÇOISE Chairperson of the committee "Safety, Security and Risks", Ministry of Economy and Finances, France;
Chair of the BNCT Working Party, OECD
ROURE
Dr. Françoise Roure holds PhDs in Industrial Economics and International Economics, University Paris-I Pantheon
Sorbonne. Formerly, Françoise Roure was Secretary-General at the French National Regulatory Authority for Electronic
Communications and Head of International and European Relations at the Directorate General for Energy and Raw
Materials, Ministry in Charge of Industry.
Chair
ANDREW Director, Directorate for Science, MARTINA State Secretary, State Secretariat for Education,
WYCKOFF Technology and Innovation (STI), OECD HIRAYAMA Research and Innovation, Switzerland
Andrew Wyckoff is the Director of the OECD’s Dr. Martina Hirayama is State Secretary for
Directorate for Science, Technology and Education, Research and Innovation. She was
Innovation (STI) where he oversees OECD’s leading professor of the department of polymer
work on innovation, business dynamics, materials at ZHAW, developed and managed the
science and technology, information and Institute of Materials and Process Engineering at
communication technology policy as well as ZHAW and was director of the ZHAW School of
the statistical work associated with each of Engineering.
these areas. Andrew Wyckoff holds a BA in
Economics from the University of Vermont, and
a Master of Public Policy from the JFK School
of Government, Harvard University.
3 oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Keynote: Economic stakes and potential health impacts of neurotechnologies
19 May 2021, 13h15-14h00 CEST
TOM Chief Innovation Officer, Schmidt Futures, DAVID Senior Policy Analyst, BNCT Secretary, Science
USA WINICKOFF and Technology Policy Division (STP), OECD,
KALIL
France
Tom Kalil leads initiatives to harness David Winickoff is a Harvard trained lawyer. He
technology for societal challenges, improve leads work on the responsible development of
science policy, and identify and pursue 21st emerging technologies in areas such as
century moonshots. He served during the synthetic biology, neurotechnology, gene editing,
Obama administration as Deputy Director for and the bioeconomy. He came to the OECD from
Speaker Moderator
Technology and Innovation for the White a tenured professorship in bioethics at
House Office of Science and Technology Policy University of California, Berkeley, where he
and Senior Advisor for Science, Technology directed the Program on Science and
and Innovation for the National Economic Technology Studies. He is also an Affiliated
Council. Professor of Law at the SciencesPo École de
Droit where he teaches the governance of
emerging technologies.
4 oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Panel 1: Building institutional capacity to implement the Recommendation – the Swiss experience
19 May 2021, 14h00-15h00 CEST
MARCELLO Senior Researcher, Department of Health Sciences Guiding questions
IENCA and Technology, ETH Zürich, Switzerland
Dr. Marcello Ienca is a senior research fellow at the ► What contextual factors can facilitate the
Department of Health Science and Technology, and implementation of the OECD Recommendation in
a member of the Competence for Rehabilitation Switzerland?
Engineering & Science at ETH Zurich, Switzerland. ► How can the perspectives of different stakeholders
Dr. Ienca has recently been awarded a ERA-NET be harmonised?
Neuron grant for the project entitled "Hybrid Minds": ► What considerations should be prioritised to ensure
Moderator
Experiential, ethical and legal investigation of a participative and successful implementation
intelligent neuroprostheses. Together with co-PIs strategy?
from Germany and Canada he will investigate, in ► How can the Recommendation contribute to
accelerating personalised health in Switzerland and
2021-2025, the interaction between human and
beyond?
artificial cognition through neural interfaces and the
► How can the Recommendation contribute to the
resulting experiential, ethical and policy
successful clinical translation of neurotechnology?
implications.
5 oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Panel 1: Building institutional capacity to implement the Recommendation – the Swiss experience
19 May 2021, 14h00-15h00 CEST
ANTONELLA Head of stakeholder engagement for RICARDO Senior Researcher, Zurich University of Applied
SANTUCCIONE Alzheimer’s disease at Biogen; CEO of the CHAVARRIAGA Sciences (ZHAW); Chair of Working group on
CHADHA Women's Brain Project, Switzerland Neurotechnologies for brain-machine
interfacing, IEEE Standards Association
Dr. Antonella Santuccione Chadha is a medical Dr. Ricardo Chavarriaga is neuroengineer. From
doctor with expertise in clinical pathology, 2019 until present, he has been Executive-in-
neuroscience and psychiatric disorders. She is head Residence at the Geneva Center for Security Policy
of stakeholder engagement for Alzheimer’s disease in Switzerland. From 2017 until present, Ricardo
at Biogen. She is co-founder and CEO of the non- Chavarriaga has been the Chair of the Working
profit organization “Women’s Brain Project” which group on Neurotechnologies for brain-machine
is addressing the influence of sex and gender on interfacing at the IEEE Standards Association.
mental and brain diseases.
REA Future Health Technologies, Senior Programm MARY CEO, Wyss Center for Bio and
LEHNER Manager, ETH Zürich, Switzerland TOLIKAS Neuroengineering, Switzerland
Dr. Rea Lehner received her degrees in Biology, Dr. Mary Tolikas holds PhD degrees in Electrical
Human Movement Science and Neuroscience Engineering and Computer Science from the
from the University of Berne and ETH Zurich, Massachusetts Institute of Technology and an
where she continued her research at the Neural MBA degree from the MIT. She was instrumental in
Control of Movement lab as a postdoctoral the launching and growth of the Wyss Institute for
researcher. She has contributed substantially to Biologically Inspired Engineering at Harvard
the development of the Future Health University where she spent almost ten years in the
Technologies research programme at the leadership team as Operations Director. She
Singapore-ETH Centre. focuses on neuroscience research and clinical
applications.
6 oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Panel 2: Enabling societal deliberation on neurotechnology
19 May 2021, 15h10-16h30 CEST
CLAUDIA Policy Analyst, Open and Innovative Government Guiding questions
CHWALISZ Division, OECD, France
Claudia Chwalisz leads the OECD’s work on ► What are open communication approaches that have worked
innovative citizen participation, which explores to promote neurotech literacy across different communities?
the paradigm change underway towards a ► What are success factors and potential pitfalls for multi-
more participatory, deliberative, and stakeholder dialogue?
collaborative governance. Besides research, ► How to integrate results from dialog into decision making
Moderator
her work at the OECD involves coordinating the processes and public policy?
Innovative Citizen Participation Network of ► Can you give examples of stakeholder engagement processes
leading international practitioners, academics, that were fair, transparent and predictable?
public servants, and designers, as well as ► What are good practices of technology appraisal that informs
editing the OECD's online digest, Participo. public debate about neurotechnology?
JUDITH Co-director, Missions Publiques, KAFUI Psychiatrist and Associate Professor,
FERRANDO Y France DZIRASA Duke University, USA
PUIG
Acting on the local, national and global level, Kafui Dzirasa's interests focus on understanding
Missions Publiques organizes citizens’ dialogues how changes in the brain produce neurological
that involve the stakeholders concerned. It is an and mental illness. His goal is to combine his
agency specialized in the participatory fabrication engineering background, medical training, and
of public policies. Judith Ferrando Y Puig also community experience to improve outcomes for
teaches at the University Paris Panthéon- families devastated by neurological and
Sorbonne. She is co-president of the Institut de la psychiatric illness. He writes a lot about the
concertation et de la participation citoyenne. intersection of social justice and science.
7 oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Panel 2: Enabling societal deliberation on neurotechnology
19 May 2021, 15h10-16h30 CEST
LIZ Founder and principal, Liminal Creations, HILARY Director, Society Inside,
NEELEY USA SUTCLIFFE United Kingdom
Liz Neeley is the founder and principal of Liminal Hilary Sutcliffe is the director of UK-based not-
Creations, a consulting and design firm focused for-profit SocietyInside and has for more than 15
on science communication and sensemaking. Her years focused on issues of ethics and
work began in ocean conservation, and is inspired responsibility in science and technology
by more than a decade of work in storytelling and innovation. She developed and runs the TIGTech
science engagement. Liz is a lecturer at Yale initiative which focuses attention on the need for
University, in association with the National the governance and regulation of technologies,
Neuroscience Curriculum Initiative. She vice- not just the technologies themselves, to
chairs the AAAS Committee on Science and consider its own trustworthiness and earning the
Technology Engagement with the Public trust of all stakeholders, including citizens. She
(CoSTEP) and is a member of the advisory board was recently a member of the World Economic
for the Aspen Institute Science & Society Forum Agile Governance Council, previously co-
Program. She was previously the Executive chair of its Values Ethics and Innovation Council
Director of The Story Collider. and member of previous councils on Human
Rights and also Nanotechnology.
DONNA Executive Director, European Federation of Neurological Associations
WALSH (EFNA), Ireland
Donna Walsh became the Executive Director of EFNA in June 2012. Walsh’s training is in Journalism, but she has
worked with patient organisations in the neurological sector – in various roles – since leaving university. This included
work with the European Migraine and Headache Alliance (EMHA) and the Migraine Association of Ireland (MAI), as well
as being a representative to the Neurological Alliance of Ireland.
8 oe.cd/BNCT-ZurichEvent
NEURO
TECHNOLOGY
IN AND FOR SOCIETY
Keynote: Convergence of neurotechnology with other emerging technology
20 May 2021, 13h05-13h35 CEST
JENNIFER Interim Director of the Centre for Health Law, Policy and Ethics,
CHANDLER University of Ottawa, Canada
Jennifer Chandler is presently the interim director of the Centre
for Health Law, Policy and Ethics at the University of Ottawa.
She researches and writes about the legal and ethical aspects
of biomedical science and technology, with focuses on mental
health law and policy, neuroethics, organ donation and
regenerative medicine. She contributed to work on legal policy
and the administration of justice in Canada as a former
member of the Board of Directors of the Canadian Institute for
the Administration of Justice. She is coordinator of the ERA-
NET Neuron Project “Hybrid Minds” focusing on AI-based
neuroprostheses on the human nervous system. Jennifer
Chandler is also a member of the Advisory Board for the
Institute for Neurosciences, Mental Health and Addiction of the
Canadian Institutes of Health Research (CIHR).
9 oe.cd/BNCT-ZurichEventNEURO
TECHNOLOGY
IN AND FOR SOCIETY
Panel 3: Promoting stewardship and trust across the public and private sector
20 May 2021, 13h35-14h55 CEST
LYRIC Acting Associate Director for Science Policy, National Guiding questions
JORGENSON Institutes of Health (NIH), USA
Lyric A. Jorgenson, PhD, is the Acting Associate Director for ► What are the governance gaps and
Science Policy at the National Institutes of Health. In this challenges in the field of neurotechnology?
position, she provides senior leadership in the development and
oversight of policies and programs associated with emerging, ► What are examples of best practices and
high-impact issues of importance to the biomedical research good business conduct for promoting trust
Moderator enterprise and the United States Government. and trustworthiness?
She was also the Deputy Executive Director of the White House ► How to promote deeper dialogue among
stakeholders?
Cancer Moonshot Task Force in the Office of the Vice President
in the Obama administration, where she directed and
coordinated cancer-related activities across the Federal
government and worked to leverage investments across sectors
to dramatically accelerate progress in cancer prevention,
diagnosis, and treatment.
10 oe.cd/BNCT-ZurichEventNEURO
TECHNOLOGY
IN AND FOR SOCIETY
Panel 3: Promoting stewardship and trust across the public and private sector
20 May 2021, 13h35-14h55 CEST
TIM Professor, Oxford University, HUSSEINI Global Head Science for Minds,
DENISON United Kingdom MANJI Johnson & Johnson, USA
Tim Denison is Professor with a joint
As Global Head for Johnson & Johnson (J&J)
appointment in Engineering Science and Clinical
Science for Minds, Husseini Manji, MD, FRCPC
Neurosciences at Oxford University, where he
leads the new initiative aimed at addressing
explores the fundamentals of physiologic closed-
the significant unmet needs of patients with
loop systems. Prior to that, he was a Technical
neuropsychiatric and neurodegenerative
Fellow at Medtronic PLC and Vice President of
disorders. His team is working to catalyze the
Research & Core Technology for the Restorative
development of novel and improved solutions
Therapies Group, where he helped oversee the
for patients worldwide with a focus on
design of next generation neural interface and
dementia; serious mental health disorders,
algorithm technologies for the treatment of
especially those affecting youth; and
chronic neurological disease.
innovative digital solutions/technologies.
Previously, Dr. Manji was Global Therapeutic
DARÍO Senior Vice President and Director of IBM
Head for Neuroscience at Janssen Research &
GIL Research, IBM, USA
Development, one of the Pharmaceutical
Dr. Darío Gil is Senior Vice President and Companies of Johnson & Johnson. Prior to
Director of IBM Research. He is a globally joining J&J, Dr. Manji was Chief of the
recognized leader of the quantum computing Laboratory of Molecular Pathophysiology at
industry. Dr. Gil leads the technology roadmap the National Institutes of Health (NIH) and
and the technical community of IBM, directing Director of the NIH Mood and Anxiety
innovation strategies in areas including hybrid Disorders Program.
cloud, AI, quantum computing, and exploratory
11 science. oe.cd/BNCT-ZurichEventNEURO
TECHNOLOGY
IN AND FOR SOCIETY
Panel 3: Promoting stewardship and trust across the public and private sector
20 May 2021, 13h35-14h55 CEST
JULIE Cofounder & CEO, Braintale; President, THOMAS Professor, Freiburg University,
RACHLINE LallianSe, France STIEGLITZ Germany
Dr. Julie Rachline is a serial entrepreneur with a Thomas Stieglitz is an electrical engineer by
PhD in Neuropharmacology from Sorbonne education and Professor of Biomedical
University. She is cofounder and CEO of Microtechnology at the University Freiburg. He
Braintale, a universal brain measures company. focuses on miniaturized neural implants for
Braintale establishes new references for clinical both, fundamental neuroscience research and
decisions and clinical developments in intensive clinical applications (sensory feedback,
care and neurology. Dr. Rachline serves as monitoring, neuroprosthetics). He has co-
President of LallianSe, a life sciences integrator founded two startups, CorTec and neuroloop,
which transforms life sciences innovations onto both active in neural implants. As a policy
economic successes since 2015. Immerged expert, he was also involved in the development
within hospital-based living LABS (Pïtié- of the OECD Recommendation on Responsible
Salpêtrière and Bichat hospitals in Paris), Innovation in Neurotechnology.
LallianSe accelerates innovation in Europe.
12 oe.cd/BNCT-ZurichEventNEURO
TECHNOLOGY
IN AND FOR SOCIETY
Expert talk: Monitoring implementation activities - towards the development of indicators
20 May 2021, 15h05-15h25 CEST
EMAD Senior Researcher, Technical University Delft,
YAGHMAEI the Netherlands
Dr. Emad Yaghmaei is a Senior Researcher at the
Faculty of Technology, Policy and Management at Delft
University of Technology and CEO of YAGHMA. His
work covers governance of organisations and
processes with focus on their ethical, social, and
governmental impacts. He is specially interested in
designing and developing necessary policies and
methods for implementation, evaluation, and
assessment of responsible innovation and non-financial
values within industrial context.
13 oe.cd/BNCT-ZurichEventNEURO
TECHNOLOGY
IN AND FOR SOCIETY
Roundtable: next steps in the implementation of the Recommendation
20 May 2021, 15h25-16h35 CEST
HARRIS A. MD PhD, President, PRODEO; Co-Lead, OECD SUNG-JIN Co-chair of the IBI Neuroethics Working Group;
EYRE Neuroscience-inspired Policy Initiative JEONG Principal Researcher, Korea Brain Research
Institute
Dr. Harris A. Eyre focuses on understanding and Dr. Sung-Jin Jeong received her Ph.D. in
addressing brain health disorders. He is Molecular Biology from Seoul National
President of PRODEO, a boutique group of brain University. She is Co-chair of the International
health executives which support the Brain Initiative (IBI) Neuroethics working group
development and scaling of novel technologies. and Principal Researcher at the Korean Brain
His policy work is driven through the OECD Research Institute, and Secretary General of the
Initiative. He is lead-editor of Convergence International Brain Research Organization
Mental Health, a 2021 book with Oxford (IBRO).
University Press.
DAFNA Chief of Section Bioethics and Ethics of Science,
FEINHOLZ UNESCO
Dafna Feinholz has a PhD in Research Psychology (UIA Mexico) and a Master in Bioethics (Universidad Complutense,
Madrid, Spain). Since September 2009, she is the Chief of the Bioethics and Ethics of Science Section at UNESCO and is
also responsible for the Secretariat of UNESCO’s advisory bodies in Bioethics and Ethics of Science and Technology:
IBC, IGBC and COMEST.
In this capacity, she leads work to support the capacity of Member States to deal with bioethical and ethics of science
and technology issues. Key outputs are UNESCO’s series of Guidelines for National Bioethics Committees, among them:
Guide 4: Bioethics committees and public policy; Guide 5: Bioethics committees and public engagement.
14 oe.cd/BNCT-ZurichEventNEURO
TECHNOLOGY
IN AND FOR SOCIETY
Roundtable: next steps in the implementation of the Recommendation
20 May 2021, 15h25-16h35 CEST
LAURENCE Head of Bioethics Unit (DGI – Human Rights CAROLINE President, Dana Foundation
LWOFF Directorate); Secretary of the Committee on MONTOJO
Bioethics (DH-BIO), Council of Europe
Dr. Laurence Lwoff is Head of Bioethics Unit of Dr. Caroline Montojo is the president of the Dana
the Council of Europe and Secretary of the Foundation, a private philanthropic organization
intergovernmental Committee on Bioethics (DH- dedicated to advancing understanding about the
BIO). Lwoff holds a MD in physiology from the brain. Until January 2021, she was the director
University of Paris VI – Jussieu (France) and a of Life Sciences and the director of Brain
PhD in molecular biology. She joined the Council Initiatives at the Kavli Foundation. She has been
of Europe in 1991. She has been involved in the deeply involved in efforts to advance
development of the Strategic Action Plan on neuroscience, including a global movement to
Human Rights and Technologies in Biomedicine create an International Brain Initiative. Caroline
(2020-2025) and the Guide to Public Debate on Montojo holds a PhD in Psychological and Brain
Human Rights and Biomedicine. Science from the Johns Hopkins University.
15 oe.cd/BNCT-ZurichEventNEURO
TECHNOLOGY
IN AND FOR SOCIETY
Closing remarks
20 May 2021, 16h35-16h45 CEST
FRANÇOISE Chairperson of the committee "Safety, Security PATRICK Swiss State Secretariat for Education,
ROURE and Risks", Ministry of Economy and Finances, VOCK Research and Innovation (SERI)
Chair of BNCT Working Party, OECD
Dr. Françoise Roure holds PhDs in Industrial Patrick Vock works in the Strategy and Planning
Economics and International Economics, division of the Swiss State Secretary for
University Paris-I Pantheon Sorbonne. Formerly, Education, Research and Innovation (SERI). He
Roure was Secretary-General at the French acts as ambassador in the work with
National Regulatory Authority for Electronic multilateral institutions. Between 2016-2020,
©OECD/Andrew Wheeler
Communications and Head of International and Patrick Vock was Chair of the Committee for
European Relations at the Directorate General Science and Technological Policy (CSTP). He
for Energy and Raw Materials, Ministry in Charge was former chair of the Innovation and
of Industry. Technology (TIP) Working Party at the OECD. He
holds a master degree in economics from the
University of Zurich (1990), following his
postgraduate studies in European affairs at the
College of Europe (Bruges).
16 oe.cd/BNCT-ZurichEventYou can also read
